Work

Short‐duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir ( FOUR ward study)

Year: 2016

Type: article

Study design: Clinical Trial

Source: Liver International

DOI: 10.1111/liv.13335

Authors: Mark S. Sulkowski, Steve Flamm, Zeid Kayali, Eric J. Lawitz, Paul Kwo, Fiona McPhee, Anne Torbeyns, Eric A. Hughes, Eugene S. Swenson, Philip D. Yin, Misti Linaberry

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Northwestern University, Inland Empire Liver Foundation, The University of Texas at San Antonio Health Science Center, Texas Liver Institute, Indiana University Bloomington, Indiana University, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Belgium)

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, National Institutes of Health, National Institute on Drug Abuse

Awards: G2456272280, G9000121099

OpenAlex ID: W2560427643

FWCI: 4.25

Cites: 16

Cited by: 34

Related to: 10